To celebrate the release of my first book in print, I’m giving away a prize to a random purchaser of my novelette “The Icelandic Cure.”
Since the story is about genetic engineering, I thought a DNA-related prize would be appropriate.
The Prize
One 23andMe Health + Ancestry Kit (retail price $199)
or
$150 cash (if you’ve already gotten your 23andMe results, or don’t want them)
The Rules
Contest rules are simple:
- Purchase “The Icelandic Cure” on amazon.com, directly from Omnidawn, or anywhere else.
- Follow me on Twitter and DM me a proof of purchase (a screenshot of your email receipt, a picture of the book on your coffee table, etc.). Or, if you don’t use Twitter, email the proof of purchase to jd_moyer at looq.com. Either way is fine.
- To double your chances of winning, share this post with your followers on Twitter and tag me AND/OR leave a review on amazon or goodreads and send me a link to the review. So far the book only has one review on each site, so reviews are especially appreciated!
The contest will run until June 15, 2018. I’ll announce the winner and award the prize by June 22nd.
I don’t directly profit from sales of the book–I won the 2016 Omnidawn Fabulist Fiction prize which granted a flat fee prize of $1000. But I’d still like to do what I can to boost sales and promote the story.
This is a strong, thoughtful story that inspires hope for the future, curiosity about medical progress, and sheer terror at what might be done in its name.âPublishers Weekly
Thank you, and good luck!
[twitter_follow screen_name=”johndavidmoyer” show_count=False size=Large]
The contest winner is Hardy Stegall of Pretty Prairie, Kansas. Congratulations Hardy!
I have a new short story in Issue #11 of Compelling Science Fiction called “Targeted Behavior.” It’s about a tech startup in San Francisco attempting to “solve” homelessness via pharmaceutical means (which, as you might guess, doesn’t go quite as planned). It’s free to read online, but please consider subscribing or purchasing the Kindle edition anyway. Editor Joe Stech is doing great work.